| Project/Area Number |
16K09372
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Saitama Medical University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
NAKAYAMA nobuhaki
UCHIDA yoshihito
UEMURA hayato
|
|---|
| Project Period (FY) |
2016-04-01 – 2019-03-31
|
| Project Status |
Completed (Fiscal Year 2018)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | Hepatitis C virus / Direct-acting antivirals / RAS / NS5A複製複合体阻害薬 / NS5Bポリメラーゼ阻害薬 / HCV / DAA / NS5A / NS5B / NS5A複製複合体 / NS5Bポリメラーゼ / Bioinformatics / Deep sequencing / 肝臓学 / 内科 / ウイルス / 薬剤反応性 |
|---|
| Outline of Final Research Achievements |
Hepatitis C virus (HCV) has been the most frequent etiology of hepatocellular carcinoma, but can be eradicated from the liver after antiviral therapies using direct-acting antivirals (DAAs). In a small part of patients, however, virologic failure develops during and after DAA therapies. First, we evaluated the mechanisms involved in the development of HCV strains carrying resistance-associated substitutions (RASs) in the NS5A region, and demonstrated the Othello failure involved in the development of virologic failure in patients without signature NS5A-RASs at baseline, and 2-hit failure associating occurrence of extremely severe tolerant HCV strains against NS5A replication complex inhibitors, such as NS5A-P32 deletion. Moreover, we found NS5B-A218S as a factor involved in derangement of antiviral efficacy of NS5A polymerase inhibitors, and nominated such phenomenon as Tom & Jerry failure.
|
| Academic Significance and Societal Importance of the Research Achievements |
DAAs治療不成功はNS5A-L31M/Y93Hで生じるが，これがない場合の不成功要因としてNS5A-L28M/R30Qを見出した。この置換は耐性でないが，耐性NS5A-L28M/R30Q/Y93Hが混在し，これが野生株と置換した（Othello現象）。一方，NS3/4Aプロテアーゼ阻害薬で不成功時には，NS5Aの塩基配列が変化し，NS5A複製複合体阻害薬投与後に高度耐性NS5A-P32欠損が発生した（2-ヒット現象）。一方，NS5Bポリメラーゼ阻害薬の効果はNS5B-A218Sによって減退することを見出した（Tom & Jerry現象）。これらの解明でRAS発生を防ぐ治療法確立に貢献した。
|
